Brands should not imply that these ingredients help people taking GLP-1 medications maintain muscle unless the claim is supported by evidence that is relevant to GLP-1 users, the finished formulation, and the intended serving size
How do you get GLP-1 approved
2.7% of placebo-treated patients
Ethics declarations Competing interests The author declares associations with the following companies: Astra-Zeneca, Bristol-Myers Squibb, Merck Sharpe & Dohme, NovoNordisk and Sanofi-Aventis (advisory board membership
Age matters because our bodies lose glutathione as we grow older
Studies show that this co-administration produces a significantly greater increase in GH than either peptide administered alonea synergistic, not merely additive, effect